Valuation Lamdong Pharmaceutical

Stocks

End-of-day quote HANOI S.E. Other stock markets 2026-07-23			5-day change	1st Jan Change
8,200.00 ^VND	-1.20%		+2.50%	-26.13%

04-23	Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
01-27	Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	201,980	129,572	148,053
Change	-	-35.85%	14.26%
Enterprise Value (EV) ¹	247,718	167,441	184,198
Change	-	-32.41%	10.01%
P/E	-10x	18.7x	5.47x
PBR	2.19x	1.31x	1.09x
PEG	-	-0x	0x
Capitalization / Revenue	1.09x	0.59x	0.61x
EV / Revenue	1.33x	0.77x	0.76x
EV / EBITDA	-60.3x	8.33x	7.97x
EV / EBIT	-20.1x	12.6x	10.5x
EV / FCF	29.8x	29x	-1.39x
FCF Yield	3.36%	3.44%	-72%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1,583	545	2,030
Distribution rate	-	-	-
Net sales ¹	186,001	217,958	243,906
EBITDA ¹	-4,110	20,093	23,115
EBIT ¹	-12,347	13,280	17,460
Net income ¹	-20,105	6,919	28,558
Net Debt ¹	45,738	37,869	36,145
Reference price ²	15,900.00	10,200.00	11,100.00
Nbr of stocks (in thousands)	12,703	12,703	13,338
Announcement Date	4/2/25	4/2/25	4/7/26

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LAMDONG PHARMACEUTICAL	-	-	-	-	5.91M
ELI LILLY AND COMPANY	34.57x	12.36x	25.86x	0.58%	1,037B
JOHNSON & JOHNSON	27.4x	6.26x	17.33x	2.1%	615B
ABBVIE INC.	33x	7.49x	15.4x	2.71%	448B
ROCHE HOLDING AG	17.76x	4.4x	10.85x	3.01%	326B
NOVARTIS AG	21.11x	5.63x	13.79x	2.84%	293B
ASTRAZENECA PLC	21.21x	4.47x	12.37x	1.97%	264B
NOVO NORDISK A/S	14.09x	5.24x	10.8x	3.55%	216B
AMGEN INC.	24.01x	6.34x	11.18x	2.76%	198B
GILEAD SCIENCES, INC.	-46.95x	5.62x	31.09x	2.53%	162B
Average	16.24x	6.43x	16.52x	2.45%	355.74B
Weighted average by Cap.	23.96x	7.75x	18.21x	2.01%